Uncover key drivers, emerging technologies, and competitive movements shaping the non-opioid pain treatment market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Non-Opioid Pain Treatment Market Size?

The non-opioid pain treatment market has experienced robust expansion in recent times. Projections indicate a rise from $50.63 billion in 2024 to $55.31 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 9.2%. Historically, this expansion has been driven by factors such as the increasing prevalence of chronic pain, a growing patient preference for safer alternatives, heightened public awareness concerning opioid risks, a surging demand for non-addictive treatments, and expanding initiatives from healthcare providers.

The non-opioid pain treatment market is projected to experience significant expansion in the coming years. This market is anticipated to reach a valuation of $77.67 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period is attributable to factors such as increasing demand for personalized pain management, a rising adoption of non-opioid therapies, an expanding geriatric population, greater investment in non-opioid drug development, and improved government support and reimbursement policies. Prominent trends for the forecast period include advancements in drug delivery systems, the integration of multidisciplinary care approaches, technology-driven personalized medicine, ongoing developments in non-opioid pharmacological options, and improvements in patient monitoring tools.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp

Which Factors Are Steering Growth In The Non-Opioid Pain Treatment Market?

An increasing occurrence of sports-related injuries is anticipated to drive expansion in the non-opioid pain treatment market moving ahead. These injuries are defined as physical harm sustained during or consequent to participation in sports or exercise activities. The uptick in sports-related injuries stems from greater engagement in intense athletic and leisure pursuits, subjecting participants to an elevated risk of physical trauma. Non-opioid pain management proves beneficial for such injuries, delivering effective pain alleviation and reducing inflammation without the dangers linked to opioid consumption, thereby aiding quicker recovery, enhanced function, and more secure long-term care. For instance, in October 2024, according to the Howden Group Holdings Ltd, a UK-based insurance intermediary company, in the 2023/24 football season, Europe’s top five leagues recorded 4,123 injuries, marking a 4% increase compared to the previous season. Consequently, the growing frequency of sports-related injuries is fueling the expansion of the non-opioid pain treatment market.

How Is The Non-Opioid Pain Treatment Market Organized By Different Segments?

The non-opioid pain treatment market covered in this report is segmented

1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products

2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies

5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications

Subsegments:

1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products

2) By Menthol Containing: Topical Creams, Gels, Sprays

3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements

4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A

5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays

6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices

What Current And Upcoming Trends Are Shaping The Non-Opioid Pain Treatment Market?

Companies operating within the non-opioid pain treatment market are heavily focused on advancements in drug formulations, specifically non-opioid oral treatments, to provide efficient pain relief and diminish the risks associated with opioid dependency and use. Non-opioid oral treatment encompasses pain-relieving medications administered orally that do not contain opioids and function via alternative means, such as lessening inflammation, adjusting nerve signals, or acting on particular receptors, thereby managing pain without the addiction potential or respiratory complications frequently linked to opioids. For example, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, launched JOURNAVX, an innovative, first-in-class non-opioid therapy designed to effectively alleviate moderate-to-severe acute pain. This advanced non-opioid treatment modulates pain pathways with precision, presents a beneficial safety profile, and exhibits a rapid onset of action, leading to strong pain management, reduced chances of dependency, and improved patient well-being. It guarantees targeted pain relief, lowers addiction risks, and contributes to quicker recovery and an enhanced quality of life for patients experiencing acute pain.

Who Are The Most Influential Companies In The Non-Opioid Pain Treatment Market?

Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report

Which Region Dominates The Non-Opioid Pain Treatment Market Today?

North America was the largest region in the non-opioid pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27366&type=smp

Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2025, By The Business Research Company

Polyethylene Pipes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

Polyolefin Pipes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report

Plastic Pipes And Pipe Fittings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plastic-pipes-and-pipe-fittings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model